Hepatobiliar manifestations in inflammatory bowel disease: A practical approach
摘要
Inflammatory bowel diseases(IBD)are associated with various hepatobiliary disorders.They can occur at any moment in the course of the disease or associated with the treatment.The prevalence of liver dysfunction can reach up to 50%in different studies.Nonalcoholic fatty liver disease is considered the most common hepatobiliary complication in IBD,while primary sclerosing cholangitis is the most specific.Management of hepatic manifestations in IBD involves a multidisciplinary approach that includes a high index of suspicion and joint management with hepatologists.The medical confrontation with abnormal liver tests must include an exhaustive study to determine if these patterns can be related to IBD,associated diseases or to the therapies used.
参考文献6
-
1John Aranake-Chrisinger,Themistocles Dassopoulos,Yan Yan,ILKe Nalbantoglu.Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation[J].World Journal of Gastroenterology,2020,26(28):4126-4139. 被引量:4
-
2Vinícius Remus Ballotin,Lucas Goldmann Bigarella,Floriano Riva,Georgia Onzi,Raul Angelo Balbinot,Silvana Sartori Balbinot,Jonathan Soldera.Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease:A case report and systematic review[J].World Journal of Clinical Cases,2020,8(18):4075-4093. 被引量:4
-
3Peter Hoffmann,Victoria Jung,Rouven Behnisch,Annika Gauss.Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases:A cross-sectional and longitudinal analysis[J].World Journal of Gastroenterology,2020,26(46):7367-7381. 被引量:8
-
4tomas koller,martina galambosova,simona filakovska,michaela kubincova,tibor hlavaty,jozef toth,anna krajcovicova,juraj payer.Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study[J].World Journal of Gastroenterology,2017,23(22):4102-4111. 被引量:8
-
5Stefano Sansone,Maria Guarino,Fabiana Castiglione,Antonio Rispo,Francesco Auriemma,Ilaria Loperto,Matilde Rea,Nicola Caporaso,Filomena Morisco.Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease[J].World Journal of Gastroenterology,2014,20(13):3516-3524. 被引量:9
-
6María Rojas-Feria,Manuel Castro,Emilio Suárez,Javier Ampuero,Manuel Romero-Gómez.Hepatobiliary manifestations in inflammatory bowel disease: The gut,the drugs and the liver[J].World Journal of Gastroenterology,2013,19(42):7327-7340. 被引量:14
二级参考文献79
-
1GundaMillonig,MichaelaKern,OthmarLudwiczek,KarinNachbaur,WolfgangVogel.Subfulminant hepatitis B after infliximab in Crohn's disease:Need for HBV-screening?[J].World Journal of Gastroenterology,2006,12(6):974-976. 被引量:9
-
2Achuthan Sourianarayanane,Gaurav Garg,Thomas H. Smith,Mujtaba I. Butt,Arthur J. McCullough,Bo Shen.Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease[J]. Journal of Crohn’s and Colitis . 2013 (8)
-
3Marwan Ghabril,Herbert L. Bonkovsky,Clarissa Kum,Tim Davern,Paul H. Hayashi,David E. Kleiner,Jose Serrano,Jim Rochon,Robert J. Fontana,Maurizio Bonacini.Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases[J]. Clinical Gastroenterology and Hepatology . 2013 (5)
-
4Albert J. Czaja.The Overlap Syndromes of Autoimmune Hepatitis[J]. Digestive Diseases and Sciences . 2013 (2)
-
5Parag Mahale,Dimitrios P. Kontoyiannis,Roy F. Chemaly,Ying Jiang,Jessica P. Hwang,Marta Davila,Harrys A. Torres.Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients[J]. Journal of Hepatology . 2012 (6)
-
6Emanuele Sinagra,Emma Aragona,Claudia Romano,Simonetta Maisano,Ambrogio Orlando,Roberto Virdone,Lorenzo Tesè,Irene Modesto,Valeria Criscuoli,Mario Cottone,Paolo Gionchetti.The Role of Portal Vein Thrombosis in the Clinical Course of Inflammatory Bowel Diseases: Report on Three Cases and Review of the Literature[J]. <journal-title>Gastroenterology Research and Practice . 2012
-
7European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection[J]. Journal of Hepatology . 2012 (1)
-
8María Chaparro,María Trapero-Marugán,Mercedes Guijarro,Consuelo López,Ricardo Moreno-Otero,Javier P. Gisbert.Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: A case report and a short review of the literature[J]. Journal of Crohn’s and Colitis . 2012
-
9Marina G. Silveira.IgG4-Associated Cholangitis[J]. Clinics in Liver Disease . 2012
-
10María Buti,Javier García-Samaniego,Martín Prieto,Manuel Rodríguez,José María Sánchez-Tapias,Emilio Suárez,Rafael Esteban.Documento de consenso de la AEEH sobre el tratamiento de la infección por el virus de la hepatitis B (2012)[J]. Gastroenterologia y Hepatologia . 2012 (7)
共引文献32
-
1Daniel F.Castillo,Ricardo Caicedo,Vani Gopalareddy.Liver Abscess in a Pediatric Patient with Ulcerative Colitis: A Case Presentation[J].Journal of Clinical and Translational Hepatology,2019,7(1):93-96.
-
2万萍,白爱平,罗凤燕.炎症性肠病免疫抑制剂治疗与淋巴瘤发生的研究进展[J].细胞与分子免疫学杂志,2015,31(5):713-715. 被引量:2
-
3邹鹏,蓝程,周旭春.炎性肠病的肠外表现研究进展[J].检验医学与临床,2015,12(16):2468-2470. 被引量:2
-
4杜肇清,卢强,刘学民,吕毅,张谞丰.巨大细菌性肝脓肿经皮穿刺引流和切开引流的疗效比较[J].中华肝脏外科手术学电子杂志,2015,4(6):348-351. 被引量:7
-
5罗杏,唐永祥.从五脏相关角度探讨炎症性肠病的中医证候及病机[J].亚太传统医药,2017,13(6):74-76. 被引量:5
-
6丁祥利,严菊梅,廖旺娣.炎症性肠病与机会性感染[J].江西医药,2018,53(2):173-178. 被引量:6
-
7沈洁,杨艳兵,李森森,童永清.丙肝患者接受免疫抑制治疗对发生肝炎、丙肝病毒再激活的影响[J].实用医学杂志,2019,35(9):1421-1424. 被引量:3
-
8卢亚奇,刘璟,宋敏,陈志涛,张姮.炎症性肠病与肝胆胰病变[J].医学新知,2019,29(4):359-361. 被引量:1
-
9孙振俊.丙型肝炎治疗及护理研究进展[J].山西医药杂志,2019,48(17):2110-2112. 被引量:4
-
10王江滨.炎症性肠病与慢性肝脏疾病的关系及其管理策略[J].临床肝胆病杂志,2020,36(7):1444-1449. 被引量:3
-
1任仕萍,王学红,马臻棋.炎症性肠病肠外表现与肥胖的相关研究[J].世界最新医学信息文摘,2021(6):66-68.
-
2Stefano Mazza,Sara Soro,Maria Chiara Verga,Biagio Elvo,Francesca Ferretti,Fabrizio Cereatti,Andrea Drago,Roberto Grassia.Liver-side of inflammatory bowel diseases:Hepatobiliary and druginduced disorders[J].World Journal of Hepatology,2021,13(12):1828-1849. 被引量:1
-
3Thea von Graffenried,Mattia Rizzi,Michel Russo,Andreas Nydegger,Simon Kayemba-Kay’s.Atypical hematological manifestation of celiac disease:A case report of aplastic anemia in a 2-year-old child and review of the literature[J].Pediatric Investigation,2021,5(2):159-162.
-
4张娜,王志敢,周华山,王妍.肺硬化性肺细胞瘤7例病理学特征[J].实用医药杂志,2021,38(8):719-721.
-
5Hepatobiliary & Pancreatic Diseases International[J].Hepatobiliary & Pancreatic Diseases International,2022,21(1).
-
6Editors Hepatobiliary & Pancreatic Diseases International[J].Hepatobiliary & Pancreatic Diseases International,2021,20(6).
-
7Brief Instructions to Authors[J].Neuroscience Bulletin,2021,37(12).
-
8徐小杰,周燕,李汛.肠道微生物、昼夜节律对代谢的影响在非酒精性脂肪肝中的作用[J].生命的化学,2021,41(11):2434-2444. 被引量:1
-
9Fabrizio Citarella,Umberto Vespasiani-Gentilucci,Anna Crescenzi,Antonella Bianchi,Vladimir Virzì,Giuseppe Tonini.Liver involvement in the course of thymoma-associated multiorgan autoimmunity:The first histological description[J].Hepatobiliary & Pancreatic Diseases International,2022,21(1):86-89.
-
10Giuseppe Losurdo,Irene Vita Brescia,Chiara Lillo,Martino Mezzapesa,Michele Barone,Mariabeatrice Principi,Enzo Ierardi,Alfredo Di Leo,Maria Rendina.Liver involvement in inflammatory bowel disease: What should the clinician know?[J].World Journal of Hepatology,2021,13(11):1534-1551.